Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.
McKinney C, Stamp LK, Dalbeth N, Topless RK, Day RO, Kannangara DR, Williams KM, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, Merriman TR. McKinney C, et al. Among authors: kannangara dr. Arthritis Res Ther. 2015 Oct 13;17:288. doi: 10.1186/s13075-015-0802-3. Arthritis Res Ther. 2015. PMID: 26462562 Free PMC article.
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.
Rasheed H, McKinney C, Stamp LK, Dalbeth N, Topless RK, Day R, Kannangara D, Williams K, Smith M, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, Lu L, Stahl EA, Choi HK, So A, Merriman TR. Rasheed H, et al. PLoS One. 2016 Jan 25;11(1):e0147939. doi: 10.1371/journal.pone.0147939. eCollection 2016. PLoS One. 2016. PMID: 26808548 Free PMC article.
Xanthine oxidoreductase and its inhibitors: relevance for gout.
Day RO, Kamel B, Kannangara DR, Williams KM, Graham GG. Day RO, et al. Among authors: kannangara dr. Clin Sci (Lond). 2016 Dec 1;130(23):2167-2180. doi: 10.1042/CS20160010. Clin Sci (Lond). 2016. PMID: 27798228 Review.
Individualising the dose of allopurinol in patients with gout.
Kannangara DRW, Graham GG, Wright DFB, Stocker SL, Portek I, Pile KD, Barclay ML, Williams KM, Stamp LK, Day RO. Kannangara DRW, et al. Br J Clin Pharmacol. 2017 Sep;83(9):2015-2026. doi: 10.1111/bcp.13307. Epub 2017 May 28. Br J Clin Pharmacol. 2017. PMID: 28417592 Free PMC article. Clinical Trial.
Barriers to Care in Gout: From Prescriber to Patient.
Vaccher S, Kannangara DR, Baysari MT, Reath J, Zwar N, Williams KM, Day RO. Vaccher S, et al. Among authors: kannangara dr. J Rheumatol. 2016 Jan;43(1):144-9. doi: 10.3899/jrheum.150607. Epub 2015 Nov 15. J Rheumatol. 2016. PMID: 26568590
Allopurinol: insights from studies of dose-response relationships.
Day RO, Kannangara DR, Stocker SL, Carland JE, Williams KM, Graham GG. Day RO, et al. Among authors: kannangara dr. Expert Opin Drug Metab Toxicol. 2017 Apr;13(4):449-462. doi: 10.1080/17425255.2017.1269745. Epub 2016 Dec 20. Expert Opin Drug Metab Toxicol. 2017. PMID: 27927043 Review.
21 results